Routine board appointment with no immediate trading implications. Monitor for any future director transactions or changes in board composition.
Price Chart
Executive Summary
Eikon Therapeutics appointed Ma. Fatima D. Francisco as a Class I director effective June 15, 2026, with standard non-employee director compensation including a $50,000 annual retainer and an option to purchase 85,937 shares at $8.96 per share. This is a routine board appointment with no material financial impact.
Key Facts
- Ma. Fatima D. Francisco appointed to the Board as Class I director, effective June 15, 2026.
- She will serve on the Compensation Committee.
- Annual retainer of $50,000 paid quarterly, prorated for partial service.
- Initial option grant of 85,937 shares at $8.96 per share, vesting monthly over 48 months.
- Standard indemnification agreement entered into.
Financial Impact
Standard director compensation: annual retainer of $50,000 and option grant valued at approximately $770,000 using Black-Scholes (based on 85,937 shares at $8.96 exercise price, but actual value not disclosed).
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-265861 |
| Document: 0001193125-26-265861-index-headers.html | 0001193125-26-265861 |
| Document: 0001193125-26-265861-index.html | 0001193125-26-265861 |
| Document: 0001193125-26-265861.txt | 0001193125-26-265861 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 26, 2026 today | 8-K | $7.48 | awaiting T+20 | — | $6.68 (−10.66%) |
Oct 26, 2026 today | Press Release | $7.48 | awaiting T+20 | — | $6.68 (−10.66%) |
Oct 23, 2026 3d ago | 8-K | $8.01 | awaiting T+20 | — | $6.68 (−16.57%) |
Oct 7, 2026 18d ago | SC 13G/A | $7.54 | awaiting T+20 | — | $6.68 (−11.37%) |
Oct 2, 2026 23d ago | SC 13G/A | $7.33 | awaiting T+20 | — | $6.68 (−8.83%) |
Sep 22, 2026 4w ago | Institutional Cluster | $8.98 $8.18 | ▼ −8.91% | ▼ −8.35% | $6.68 (−25.58%) |
Sep 8, 2026 6w ago | Insider Buy | $10.73 $7.54 | ▼ −29.73% | ▼ −31.67% | $6.68 (−37.72%) |
Sep 3, 2026 7w ago | Press Release | $10.96 $8.04 | ▼ −26.64% | ▼ −25.52% | $6.68 (−39.03%) |
Aug 13, 2026 10w ago | 8-K | $11.05 $9.36 | ▼ −15.29% | ▼ −13.30% | $6.68 (−39.52%) |
Jul 20, 2026 14w ago | Press Release | $9.65 $10.47 | ▲ +8.50% | ▲ +4.38% | $6.68 (−30.75%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers